US Patent Issued to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL on June 30 for "Recombinant adeno-associated virus products and methods for treating dystroglycanopathies and laminin-deficient muscular dystrophies" (Ohio Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,617, issued on June 30, was assigned to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (Columbus, Ohio).

"Recombinant adeno-associated virus products and methods for treating dystroglycanopathies and laminin-deficient muscular dystrophies" was invented by Paul Taylor Martin (Bexley, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Products and methods for treating dystroglycanopathies and laminin-deficient muscular dystrophies are provided. In the methods, a protein including a linker domain, such as the heparin-binding domain of Heparin-Binding Epidermal Growth Factor-Like Growth Factor (HBEGF), is delivered to patients."

The patent was f...